SGD
Live / Registered — Registered — partial invalidation of extension of protection (as of 11 Sept 2024)
What this means for you
Registered since 13 Jun 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79193398
- Registration number
- 5220416
- Mark type
- Stylized text
- Filed
- 02 Jun 2016
- Published for opposition
- 28 Mar 2017
- Registered
- 13 Jun 2017
- Attorney of record
- Jeffrey H. Handelsman
Goods and services
- Class 001 — Chemicals: Chemical preparations for use in industry [ , science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; fertilizing preparations; fire-extinguishing compositions; tempering preparations for use in and soldering ] ; chemical substances for preserving foodstuffs [ ; tanning agents for use in the manufacture of leather, namely, oils for tanning leather; adhesives for use in industry; alkaloids for industrial purposes; Methyl and Acetic acid esters; acids ]
- Class 005 — Pharmaceuticals: [ Pharmaceutical, medical and veterinary preparations for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Dietetic substances and foodstuffs for medical and veterinary use, namely, antidepressant for companion animals, lice treatment; Disinfectants, preparations for destroying vermin; Fungicides, herbicides; Alkaloids for medical use; Analgesics; General anesthetics; ] Chemical preparations for medical use [ ; Chemical preparations for pharmaceutical use for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Chemical preparations for veterinary use, namely, for antidepressant for companion animals, lice treatment; Cellulose esters for pharmaceutical use; Hormones for medical use; Potassium salts for medical use, namely, medicated bath salts; Preparations for acne treatments; Controlled substances, namely, prescription narcotics; Opiates; Pharmaceutical preparations, namely, for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Medicine, namely, sulfonamides; Veterinary preparations for treatment of depression for companion animals, lice treatment; Salts for medical use for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Pharmaceutical alcohols, medicinal alcohols; Medicines for human medicine for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Medicines for veterinary use for treatment of depression for companion animals, lice treatment; Medicines for dental use for local anesthetics; Chemical-pharmaceutical preparations for injections for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Chemical preparations for medical or veterinary use for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection, treatment of depression for companion animals, lice treatment and veterinary preparations for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Dietetic substances and foodstuffs for medical and veterinary use, namely, antidepressant for companion animals, lice treatment; Disinfectants, preparations for destroying vermin; Fungicides, herbicides; Alkaloids for medical use; Analgesics; General anesthetics; Chemical preparations for medical use; Chemical preparations for pharmaceutical use for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Chemical preparations for veterinary use, namely, for antidepressant for companion animals, lice treatment; Cellulose esters for pharmaceutical use; Hormones for medical use; Potassium salts for medical use, namely, medicated bath salts; Preparations for acne treatments; Controlled substances, namely, prescription narcotics; Opiates; Pharmaceutical preparations, namely, for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Medicine, namely, sulfonamides; Veterinary preparations for treatment of depression for companion animals, lice treatment; Salts for medical use for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Pharmaceutical alcohols, medicinal alcohols; Medicines for human medicines for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Medicines for veterinary use for treatment of depression for companion animals, lice treatment; Medicines for dental use for local anesthetics; Chemical-pharmaceutical preparations for injections, treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection; Chemical preparations for medical or veterinary use for treatment of benign prostate hyperplasia, depression, chronic myeloid leukaemia, glaucoma, ocular hypertension, hypertension, hypotension, asthma, schizophrenia, bipolar disorder, diabetes, mental illness, migraines, cough and cold, formation of blood clots, addiction, skin disorders, central nervous system diseases, urinary tract infection, treatment of depression for companion animals, lice treatment ]
- Class 040 — Treatment of materials: [ Treatment of materials in the nature of spry drying, milling, micronisation, nitration, hydrogenation, phosgenation, halogenation, oxidation, reduction; ] [ Custom manufacture of pharmaceutical products per customer order and in accordance with customer requirements; ] [ custom manufacture of pharmaceutical products as per customer order and in accordance with customer requirements, namely, acetal, aldehyds, alkaloids, esters, ketones, mercaptan, oxalates, acids, vitamins and ingredients used in the manufacture of medicines against cancer ]
Owner
- Siegfried Holding AG, Zofingen, CH
- Siegfried Holding AG, Zofingen, CH
- Siegfried Holding AG, Zofingen, CH
Prosecution history
- 12 Mar 2026 — INTERNATIONAL REGISTRATION RENEWED
- 27 Sept 2025 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 02 Sept 2025 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
- 01 Sept 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 01 Sept 2025 — INVALIDATION PROCESSED
- 12 May 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 11 Sept 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 11 Sept 2024 — REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
- 09 Apr 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Aug 2023 — TEAS SECTION 71 & 15 RECEIVED
- 23 Jun 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 05 Nov 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 13 Jun 2022 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 30 Jul 2020 — NEW REPRESENTATIVE AT IB RECEIVED
- 08 May 2019 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE